Literature DB >> 25211268

Extralevatory abdominoperineal excision (ELAPE) does not result in reduced rate of tumor perforation or rate of positive circumferential resection margin: a nationwide database study.

Mads Klein1, Anders Fischer, Jacob Rosenberg, Ismail Gögenur.   

Abstract

OBJECTIVE: To evaluate the oncological results and possible benefits associated with extralevatory abdominoperineal excision (ELAPE) when compared with conventional abdominoperineal excision (APE).
BACKGROUND: ELAPE was introduced in 2007 with the purpose of reducing the rate of positive resection margins after resection of low rectal cancers. Preliminary studies have shown promising results. No large-scale or nationwide data have been presented.
METHODS: Database study based on data from the Danish Colorectal Cancer Group's prospective database. Data on all ELAPEs and APEs performed in Denmark in the period January 1, 2009, through August 2012 were retrieved and evaluated for differences in demography, tumor characteristics, and oncological results. Uni- and multivariate logistic regression analyses were performed to identify risk factors for resection with a positive circumferential resection margin (CRM+).
RESULTS: A total of 554 patients were included, 301(54%) were operated by ELAPE; 253(46%) by APE. Sixty-three percent were men, median (interquartile range) age was 69 (61-76 years) years, and tumors removed had predominantly T-stages T2 and T3 (32% and 45%, respectively). Overall, CRM+ was found in 13% of patients. When divided according to type of procedure, we found no significant differences in demography and tumor T- and N-stages. Resections with a CRM+ were more common after ELAPE (16% vs 7%; P = 0.006). After uni- and multivariate logistic regression analyses, surgery by ELAPE remained a risk factor for a CRM+ [odds ratio, 2.59 (95% confidence interval, 1.31-5.12); P = 0.006).
CONCLUSIONS: In this nationwide study, resection of low rectal cancers by ELAPE did not improve short-term oncological results, when compared with conventional APE.

Entities:  

Mesh:

Year:  2015        PMID: 25211268     DOI: 10.1097/SLA.0000000000000910

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Anja Sims; Thomas Kittner; Eric Puffer; Joerg Zimmer; Dorothea Bleyl; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

Review 2.  [Evidence-based surgery of rectal cancer].

Authors:  M Grade; H Flebbe; B M Ghadimi
Journal:  Chirurg       Date:  2019-05       Impact factor: 0.955

3.  Laparoscopic translevator approach to abdominoperineal resection for rectal adenocarcinoma: feasibility and short-term oncologic outcomes.

Authors:  Vanessa N Palter; Steven MacLellan; Shady Ashamalla
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

4.  Mucinous adenocarcinoma of perianal region: an uncommon disease treated with neo-adjuvant chemo-radiation.

Authors:  Abhishek Purkayastha; Neelam Sharma; Vibha Dutta; Niharika Bisht; Tejas Pandya
Journal:  Transl Gastroenterol Hepatol       Date:  2016-06-21

5.  Extralevator versus standard abdominoperineal excision in locally advanced rectal cancer: a retrospective study with long-term follow-up.

Authors:  Anu Carpelan; J Karvonen; P Varpe; A Rantala; A Kaljonen; J Grönroos; H Huhtinen
Journal:  Int J Colorectal Dis       Date:  2018-02-14       Impact factor: 2.571

Review 6.  Abdominoperineal Resection for Rectal Cancer in the Twenty-First Century: Indications, Techniques, and Outcomes.

Authors:  Alexander T Hawkins; Katherine Albutt; Paul E Wise; Karim Alavi; Ranjan Sudan; Andreas M Kaiser; Liliana Bordeianou
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

7.  Dynamic magnetic resonance imaging evaluation of pelvic reconstruction with porcine dermal collagen mesh following extra-levator abdominoperineal excision for primary rectal cancer.

Authors:  Adam Dinnewitzer; Matthias Meissnitzer; Thomas Meissnitzer; Clemens Nawara; Christoph Augschöll; Selina Buchner; Franz Mayer; Dietmar Öfner
Journal:  Int J Colorectal Dis       Date:  2015-02-21       Impact factor: 2.571

8.  A tailored approach to abdominoperineal resection for rectal cancer: multicentre analysis of short-term outcomes and impact on oncological survival.

Authors:  Muhammad Tayyab; H Zaidi; P Vieira; T Qureshi; N Figueiredo; A Parvaiz
Journal:  Langenbecks Arch Surg       Date:  2021-02-27       Impact factor: 3.445

Review 9.  Advances and challenges in treatment of locally advanced rectal cancer.

Authors:  J Joshua Smith; Julio Garcia-Aguilar
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

10.  Similar long-term overall and disease-free survival after conventional and extralevator abdominoperineal excision-a nationwide study.

Authors:  Mads Klein; Emilie Colov; Ismail Gögenur
Journal:  Int J Colorectal Dis       Date:  2016-04-29       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.